nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—pancreatic cancer—bile duct cancer	0.936	1	CtDrD
Tamoxifen—ABCB11—bile duct—bile duct cancer	0.0119	0.192	CbGeAlD
Tamoxifen—ABCB11—bile—bile duct cancer	0.00913	0.148	CbGeAlD
Tamoxifen—ABCC2—bile duct—bile duct cancer	0.00604	0.0977	CbGeAlD
Tamoxifen—ABCC2—bile—bile duct cancer	0.00464	0.0751	CbGeAlD
Tamoxifen—CES1—gall bladder—bile duct cancer	0.00198	0.032	CbGeAlD
Tamoxifen—EBPL—liver—bile duct cancer	0.0015	0.0243	CbGeAlD
Tamoxifen—EBP—liver—bile duct cancer	0.00144	0.0233	CbGeAlD
Tamoxifen—DHCR7—pancreas—bile duct cancer	0.00134	0.0216	CbGeAlD
Tamoxifen—ESRRA—pancreas—bile duct cancer	0.00132	0.0213	CbGeAlD
Tamoxifen—SULT1A1—liver—bile duct cancer	0.0012	0.0193	CbGeAlD
Tamoxifen—EBPL—lymph node—bile duct cancer	0.00115	0.0186	CbGeAlD
Tamoxifen—UGT1A4—liver—bile duct cancer	0.00104	0.0169	CbGeAlD
Tamoxifen—SULT1A1—lymph node—bile duct cancer	0.000917	0.0148	CbGeAlD
Tamoxifen—DHCR7—liver—bile duct cancer	0.00085	0.0137	CbGeAlD
Tamoxifen—FMO1—liver—bile duct cancer	0.00085	0.0137	CbGeAlD
Tamoxifen—ESRRA—liver—bile duct cancer	0.000837	0.0135	CbGeAlD
Tamoxifen—ABCB11—liver—bile duct cancer	0.000743	0.012	CbGeAlD
Tamoxifen—FMO3—liver—bile duct cancer	0.000735	0.0119	CbGeAlD
Tamoxifen—CYP3A7—liver—bile duct cancer	0.000727	0.0117	CbGeAlD
Tamoxifen—DHCR7—lymph node—bile duct cancer	0.000652	0.0105	CbGeAlD
Tamoxifen—FMO1—lymph node—bile duct cancer	0.000652	0.0105	CbGeAlD
Tamoxifen—ESRRA—lymph node—bile duct cancer	0.000642	0.0104	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—liver—bile duct cancer	0.000618	0.00999	CbGeAlD
Tamoxifen—SIGMAR1—pancreas—bile duct cancer	0.000612	0.00989	CbGeAlD
Tamoxifen—CES1—liver—bile duct cancer	0.00058	0.00938	CbGeAlD
Tamoxifen—FMO3—lymph node—bile duct cancer	0.000563	0.00911	CbGeAlD
Tamoxifen—CYP2A6—liver—bile duct cancer	0.000505	0.00816	CbGeAlD
Tamoxifen—ESR2—liver—bile duct cancer	0.000502	0.00812	CbGeAlD
Tamoxifen—CES1—lymph node—bile duct cancer	0.000445	0.00719	CbGeAlD
Tamoxifen—CYP3A5—pancreas—bile duct cancer	0.000402	0.0065	CbGeAlD
Tamoxifen—CYP19A1—liver—bile duct cancer	0.000396	0.0064	CbGeAlD
Tamoxifen—SIGMAR1—liver—bile duct cancer	0.000389	0.00629	CbGeAlD
Tamoxifen—ESR2—lymph node—bile duct cancer	0.000385	0.00623	CbGeAlD
Tamoxifen—ABCC2—liver—bile duct cancer	0.000378	0.00611	CbGeAlD
Tamoxifen—CYP1B1—liver—bile duct cancer	0.00037	0.00598	CbGeAlD
Tamoxifen—ESR1—liver—bile duct cancer	0.000344	0.00556	CbGeAlD
Tamoxifen—CYP2C19—liver—bile duct cancer	0.000325	0.00525	CbGeAlD
Tamoxifen—CYP19A1—lymph node—bile duct cancer	0.000304	0.00491	CbGeAlD
Tamoxifen—SIGMAR1—lymph node—bile duct cancer	0.000298	0.00482	CbGeAlD
Tamoxifen—ABCC2—lymph node—bile duct cancer	0.00029	0.00468	CbGeAlD
Tamoxifen—CYP1B1—lymph node—bile duct cancer	0.000284	0.00459	CbGeAlD
Tamoxifen—CYP2C8—liver—bile duct cancer	0.000283	0.00458	CbGeAlD
Tamoxifen—ABCG2—liver—bile duct cancer	0.000276	0.00445	CbGeAlD
Tamoxifen—CYP1A2—liver—bile duct cancer	0.000265	0.00429	CbGeAlD
Tamoxifen—ESR1—lymph node—bile duct cancer	0.000264	0.00426	CbGeAlD
Tamoxifen—CYP1A1—liver—bile duct cancer	0.000262	0.00423	CbGeAlD
Tamoxifen—CYP3A5—liver—bile duct cancer	0.000256	0.00413	CbGeAlD
Tamoxifen—CYP2B6—liver—bile duct cancer	0.000254	0.00411	CbGeAlD
Tamoxifen—CYP2C9—liver—bile duct cancer	0.000252	0.00407	CbGeAlD
Tamoxifen—CYP2E1—liver—bile duct cancer	0.000239	0.00386	CbGeAlD
Tamoxifen—ABCB1—pancreas—bile duct cancer	0.000214	0.00345	CbGeAlD
Tamoxifen—ABCG2—lymph node—bile duct cancer	0.000211	0.00342	CbGeAlD
Tamoxifen—CYP1A1—lymph node—bile duct cancer	0.000201	0.00324	CbGeAlD
Tamoxifen—CYP3A4—liver—bile duct cancer	0.000192	0.0031	CbGeAlD
Tamoxifen—CYP2D6—liver—bile duct cancer	0.000189	0.00305	CbGeAlD
Tamoxifen—ABCB1—liver—bile duct cancer	0.000136	0.0022	CbGeAlD
Tamoxifen—ABCB1—lymph node—bile duct cancer	0.000104	0.00168	CbGeAlD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	9.08e-06	0.00367	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—ERBB2—bile duct cancer	8.94e-06	0.00361	CbGpPWpGaD
Tamoxifen—CYP2A6—Fluoropyrimidine Activity—TP53—bile duct cancer	8.92e-06	0.0036	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MBD2—bile duct cancer	8.92e-06	0.0036	CbGpPWpGaD
Tamoxifen—CYP2A6—NRF2 pathway—TGFBR2—bile duct cancer	8.81e-06	0.00356	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—IDH1—bile duct cancer	8.71e-06	0.00352	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	8.66e-06	0.0035	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	8.56e-06	0.00346	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	8.39e-06	0.00339	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	8.21e-06	0.00331	CbGpPWpGaD
Tamoxifen—ESR1—LKB1 signaling events—TP53—bile duct cancer	8.12e-06	0.00328	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—MMP9—bile duct cancer	8.11e-06	0.00327	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	8.1e-06	0.00327	CbGpPWpGaD
Tamoxifen—CYP2A6—NRF2 pathway—HGF—bile duct cancer	8.09e-06	0.00327	CbGpPWpGaD
Tamoxifen—ESR1—Plasma membrane estrogen receptor signaling—HRAS—bile duct cancer	8.07e-06	0.00326	CbGpPWpGaD
Tamoxifen—CYP1A1—Arachidonic acid metabolism—PTGS2—bile duct cancer	8.01e-06	0.00323	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	7.92e-06	0.0032	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—IDH2—bile duct cancer	7.79e-06	0.00315	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—SLC5A5—bile duct cancer	7.58e-06	0.00306	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	7.56e-06	0.00305	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—SMAD4—bile duct cancer	7.45e-06	0.00301	CbGpPWpGaD
Tamoxifen—UGT1A4—NRF2 pathway—TGFB1—bile duct cancer	7.45e-06	0.00301	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—SLC5A5—bile duct cancer	7.44e-06	0.00301	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—FAR2—bile duct cancer	7.44e-06	0.003	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	7.39e-06	0.00298	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	7.36e-06	0.00297	CbGpPWpGaD
Tamoxifen—CYP2C8—Arachidonic acid metabolism—PTGS2—bile duct cancer	7.34e-06	0.00297	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—SLC5A5—bile duct cancer	7.19e-06	0.0029	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—FAR2—bile duct cancer	7.16e-06	0.00289	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	7.11e-06	0.00287	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	7.01e-06	0.00283	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	6.97e-06	0.00281	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—TGFB1—bile duct cancer	6.84e-06	0.00276	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	6.75e-06	0.00273	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	6.74e-06	0.00272	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—EGFR—bile duct cancer	6.7e-06	0.00271	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—IDH1—bile duct cancer	6.7e-06	0.0027	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TGFB1—bile duct cancer	6.68e-06	0.0027	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	6.66e-06	0.00269	CbGpPWpGaD
Tamoxifen—CYP2C19—Arachidonic acid metabolism—PTGS2—bile duct cancer	6.56e-06	0.00265	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—IDH2—bile duct cancer	6.53e-06	0.00264	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—FAR2—bile duct cancer	6.52e-06	0.00263	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—FAR2—bile duct cancer	6.46e-06	0.00261	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—IL6—bile duct cancer	6.35e-06	0.00257	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	6.31e-06	0.00255	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	6.19e-06	0.0025	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—SLC5A5—bile duct cancer	6.18e-06	0.0025	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	6.07e-06	0.00245	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	6.07e-06	0.00245	CbGpPWpGaD
Tamoxifen—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	5.98e-06	0.00241	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	5.93e-06	0.0024	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—FAR2—bile duct cancer	5.92e-06	0.00239	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—GNAS—bile duct cancer	5.89e-06	0.00238	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	5.82e-06	0.00235	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GNAS—bile duct cancer	5.78e-06	0.00234	CbGpPWpGaD
Tamoxifen—ESR1—ATF-2 transcription factor network—IL6—bile duct cancer	5.77e-06	0.00233	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—SLC5A5—bile duct cancer	5.75e-06	0.00232	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	5.73e-06	0.00232	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—SMAD4—bile duct cancer	5.64e-06	0.00228	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—IDH1—bile duct cancer	5.61e-06	0.00227	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—GNAS—bile duct cancer	5.59e-06	0.00226	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TP53—bile duct cancer	5.5e-06	0.00222	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	5.5e-06	0.00222	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	5.46e-06	0.0022	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	5.39e-06	0.00217	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—IL6—bile duct cancer	5.26e-06	0.00212	CbGpPWpGaD
Tamoxifen—CYP1A2—Arachidonic acid metabolism—PTGS2—bile duct cancer	5.11e-06	0.00206	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—ERBB2—bile duct cancer	5.08e-06	0.00205	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—IL6—bile duct cancer	5.03e-06	0.00203	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—HRAS—bile duct cancer	4.98e-06	0.00201	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	4.89e-06	0.00197	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	4.87e-06	0.00197	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—IDH2—bile duct cancer	4.81e-06	0.00194	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GNAS—bile duct cancer	4.8e-06	0.00194	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—FAR2—bile duct cancer	4.78e-06	0.00193	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—FAR2—bile duct cancer	4.68e-06	0.00189	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—FAR2—bile duct cancer	4.67e-06	0.00188	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MBD2—bile duct cancer	4.5e-06	0.00182	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GNAS—bile duct cancer	4.47e-06	0.0018	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	4.43e-06	0.00179	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—SLC5A5—bile duct cancer	4.42e-06	0.00178	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—FAR2—bile duct cancer	4.41e-06	0.00178	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	4.25e-06	0.00172	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	4.23e-06	0.00171	CbGpPWpGaD
Tamoxifen—ABCC2—NRF2 pathway—TGFB1—bile duct cancer	4.17e-06	0.00169	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	4.16e-06	0.00168	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	4.14e-06	0.00167	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—IDH1—bile duct cancer	4.14e-06	0.00167	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—FAR2—bile duct cancer	4.04e-06	0.00163	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	4e-06	0.00162	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	3.96e-06	0.0016	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	3.95e-06	0.00159	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	3.87e-06	0.00156	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	3.87e-06	0.00156	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—NRAS—bile duct cancer	3.87e-06	0.00156	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.85e-06	0.00156	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	3.81e-06	0.00154	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—SMAD4—bile duct cancer	3.76e-06	0.00152	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	3.74e-06	0.00151	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—SLC5A5—bile duct cancer	3.7e-06	0.0015	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	3.66e-06	0.00148	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—IDH2—bile duct cancer	3.63e-06	0.00147	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—FAR2—bile duct cancer	3.61e-06	0.00146	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—SMAD4—bile duct cancer	3.59e-06	0.00145	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	3.54e-06	0.00143	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—FAR2—bile duct cancer	3.52e-06	0.00142	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—EGFR—bile duct cancer	3.52e-06	0.00142	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—IDH2—bile duct cancer	3.5e-06	0.00141	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.44e-06	0.00139	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GNAS—bile duct cancer	3.43e-06	0.00139	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	3.4e-06	0.00137	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	3.35e-06	0.00135	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—KRAS—bile duct cancer	3.33e-06	0.00134	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	3.32e-06	0.00134	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—FAR2—bile duct cancer	3.32e-06	0.00134	CbGpPWpGaD
Tamoxifen—CYP2A6—NRF2 pathway—TGFB1—bile duct cancer	3.3e-06	0.00133	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—FAR2—bile duct cancer	3.29e-06	0.00133	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	3.21e-06	0.0013	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—IDH2—bile duct cancer	3.18e-06	0.00128	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PTGS2—bile duct cancer	3.17e-06	0.00128	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—IDH2—bile duct cancer	3.15e-06	0.00127	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—IDH1—bile duct cancer	3.12e-06	0.00126	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	3.11e-06	0.00125	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PTGS2—bile duct cancer	3.11e-06	0.00125	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	3.1e-06	0.00125	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—IDH1—bile duct cancer	3.01e-06	0.00121	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PTGS2—bile duct cancer	3e-06	0.00121	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.99e-06	0.00121	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	2.99e-06	0.00121	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	2.97e-06	0.0012	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	2.93e-06	0.00118	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—IDH2—bile duct cancer	2.89e-06	0.00117	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GNAS—bile duct cancer	2.88e-06	0.00116	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—HRAS—bile duct cancer	2.83e-06	0.00114	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—FAR2—bile duct cancer	2.81e-06	0.00114	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	2.77e-06	0.00112	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—IDH1—bile duct cancer	2.74e-06	0.0011	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—SLC5A5—bile duct cancer	2.73e-06	0.0011	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RNF43—bile duct cancer	2.72e-06	0.0011	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—IDH1—bile duct cancer	2.71e-06	0.00109	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—IL6—bile duct cancer	2.71e-06	0.00109	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	2.65e-06	0.00107	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTGS2—bile duct cancer	2.58e-06	0.00104	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.56e-06	0.00103	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—IDH1—bile duct cancer	2.49e-06	0.001	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	2.46e-06	0.000995	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTGS2—bile duct cancer	2.4e-06	0.000968	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—IDH2—bile duct cancer	2.33e-06	0.000942	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—IDH2—bile duct cancer	2.28e-06	0.000922	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—IDH2—bile duct cancer	2.28e-06	0.00092	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	2.24e-06	0.000904	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	2.19e-06	0.000884	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—FAR2—bile duct cancer	2.17e-06	0.000876	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—IDH2—bile duct cancer	2.15e-06	0.00087	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GNAS—bile duct cancer	2.12e-06	0.000857	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	2.08e-06	0.000841	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—SLC5A5—bile duct cancer	2.06e-06	0.000832	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—IDH1—bile duct cancer	2.01e-06	0.00081	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—SLC5A5—bile duct cancer	1.98e-06	0.000801	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—IDH2—bile duct cancer	1.97e-06	0.000797	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—IDH1—bile duct cancer	1.96e-06	0.000793	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—IDH1—bile duct cancer	1.96e-06	0.000791	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.93e-06	0.000779	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.86e-06	0.000751	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—IDH1—bile duct cancer	1.85e-06	0.000748	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTGS2—bile duct cancer	1.84e-06	0.000745	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—SMAD4—bile duct cancer	1.81e-06	0.00073	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—SLC5A5—bile duct cancer	1.81e-06	0.000729	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—SLC5A5—bile duct cancer	1.79e-06	0.000722	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—IDH2—bile duct cancer	1.76e-06	0.000712	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—IDH2—bile duct cancer	1.72e-06	0.000694	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—IDH1—bile duct cancer	1.7e-06	0.000686	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—SLC5A5—bile duct cancer	1.64e-06	0.000662	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—IDH2—bile duct cancer	1.62e-06	0.000654	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	1.62e-06	0.000654	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—IDH2—bile duct cancer	1.61e-06	0.000649	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GNAS—bile duct cancer	1.6e-06	0.000646	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	1.58e-06	0.000639	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	1.55e-06	0.000627	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTGS2—bile duct cancer	1.55e-06	0.000624	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GNAS—bile duct cancer	1.54e-06	0.000622	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—IDH1—bile duct cancer	1.52e-06	0.000612	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—IDH1—bile duct cancer	1.48e-06	0.000597	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	1.47e-06	0.000592	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GNAS—bile duct cancer	1.4e-06	0.000566	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—IDH1—bile duct cancer	1.39e-06	0.000563	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GNAS—bile duct cancer	1.39e-06	0.000561	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—IDH1—bile duct cancer	1.38e-06	0.000558	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—IDH2—bile duct cancer	1.37e-06	0.000554	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SLC5A5—bile duct cancer	1.32e-06	0.000534	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	1.3e-06	0.000526	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC5A5—bile duct cancer	1.3e-06	0.000523	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC5A5—bile duct cancer	1.29e-06	0.000522	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GNAS—bile duct cancer	1.27e-06	0.000514	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFBR2—bile duct cancer	1.24e-06	0.000502	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC5A5—bile duct cancer	1.22e-06	0.000493	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GNAS—bile duct cancer	1.2e-06	0.000484	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—IDH1—bile duct cancer	1.18e-06	0.000477	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SMAD4—bile duct cancer	1.18e-06	0.000475	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.14e-06	0.000462	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—bile duct cancer	1.14e-06	0.00046	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC5A5—bile duct cancer	1.12e-06	0.000452	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—IDH2—bile duct cancer	1.06e-06	0.000428	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.05e-06	0.000424	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GNAS—bile duct cancer	1.03e-06	0.000415	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GNAS—bile duct cancer	1.01e-06	0.000407	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GNAS—bile duct cancer	1e-06	0.000406	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC5A5—bile duct cancer	1e-06	0.000404	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC5A5—bile duct cancer	9.76e-07	0.000394	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GNAS—bile duct cancer	9.49e-07	0.000383	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	9.37e-07	0.000378	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC5A5—bile duct cancer	9.2e-07	0.000371	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC5A5—bile duct cancer	9.12e-07	0.000368	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—IDH1—bile duct cancer	9.11e-07	0.000368	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GNAS—bile duct cancer	8.7e-07	0.000351	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—bile duct cancer	8.6e-07	0.000347	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	8.54e-07	0.000345	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—bile duct cancer	8.28e-07	0.000334	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC5A5—bile duct cancer	7.79e-07	0.000315	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GNAS—bile duct cancer	7.77e-07	0.000314	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GNAS—bile duct cancer	7.58e-07	0.000306	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—bile duct cancer	7.53e-07	0.000304	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—bile duct cancer	7.47e-07	0.000301	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	7.3e-07	0.000295	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GNAS—bile duct cancer	7.15e-07	0.000289	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GNAS—bile duct cancer	7.08e-07	0.000286	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—bile duct cancer	6.84e-07	0.000276	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—bile duct cancer	6.58e-07	0.000266	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GNAS—bile duct cancer	6.05e-07	0.000244	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC5A5—bile duct cancer	6.01e-07	0.000243	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—bile duct cancer	5.65e-07	0.000228	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—bile duct cancer	5.52e-07	0.000223	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—bile duct cancer	5.41e-07	0.000218	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—bile duct cancer	5.4e-07	0.000218	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—bile duct cancer	5.1e-07	0.000206	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—bile duct cancer	5.01e-07	0.000202	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—bile duct cancer	4.67e-07	0.000189	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GNAS—bile duct cancer	4.67e-07	0.000189	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—bile duct cancer	4.65e-07	0.000188	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—bile duct cancer	4.56e-07	0.000184	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—bile duct cancer	4.31e-07	0.000174	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—bile duct cancer	4.17e-07	0.000168	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—bile duct cancer	4.07e-07	0.000164	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—bile duct cancer	3.84e-07	0.000155	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—bile duct cancer	3.83e-07	0.000155	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—bile duct cancer	3.8e-07	0.000154	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—bile duct cancer	3.66e-07	0.000148	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—bile duct cancer	3.51e-07	0.000142	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—bile duct cancer	3.25e-07	0.000131	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—bile duct cancer	2.51e-07	0.000101	CbGpPWpGaD
